<DOC>
	<DOCNO>NCT00041795</DOCNO>
	<brief_summary>This study ass safety efficacy Neotrofin treat peripheral neuropathy result chemotherapy cancer .</brief_summary>
	<brief_title>Neotrofin Treatment Chemotherapy-Induced Peripheral Neuropathy</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<criteria>Patient must diagnosis cancer receive receive chemotherapy result sensory motor neuropathy . Sensory motor neuropathy must &gt; /= grade 2 per Common Toxicity Criteria baseline . In patient diagnosed multiple myeloma , grade 1 sensory motor neuropathy acceptable . Patient must normal hematological cell count . Patient must life expectancy &gt; /= 3 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>July 2002</verification_date>
</DOC>